4 free views remaining today

IgA pemphigus

Description

IgA Pemphigus: An Autoimmune Blistering Disorder

IgA pemphigus, also known as intercellular IgA dermatosis, is a rare autoimmune blistering disorder. It is characterized by the presence of tissue-bound and circulating autoantibodies against the epidermal cells, leading to intraepidermal blistering.

Key Features:

  • Autoimmune Nature: IgA pemphigus is an autoimmune disease, where the body's immune system mistakenly attacks its own skin cells.
  • Intraepidermal Blistering: The disorder causes blisters to form within the epidermis, the outermost layer of the skin.
  • IgA Antibodies: The presence of IgA antibodies against the epidermal cells is a hallmark of this condition.

Types and Symptoms:

  • Intraepidermal Neutrophilic IgA Dermatosis-Type (IEN-Type): This type is characterized by neutrophils (a type of white blood cell) in the blisters.
  • Vesiculopustular Skin Disease: Lesions can form within erythematous plaques or without plaques, causing painful and pruritic pustular or vesiculobullous skin eruptions.

References:

  • [1] IgA pemphigus is an autoimmune blistering disorder. It is also called intercellular IgA dermatosis among other names.
  • [2] Immunoglobulin A (IgA) pemphigus is a group of newly characterized immune-mediated intraepidermal blistering skin diseases.
  • [3] IgA pemphigus is subdivided into intraepidermal neutrophilic IgA dermatosis-type (IEN-type), whose target antigen is still unknown (probably nondesmosomal cell surface).
  • [4] IgA pemphigus represents a more recently characterized group of autoimmune intraepidermal blistering diseases.
  • [5] Definition. IgA pemphigus is an uncommon, acquired intraepidermal vesiculopustular disorder characterized by intercellular IgA deposition in the epidermis.
  • [6] IgA pemphigus is a condition in which the IgA reaction to the keratinocyte cell surfaces is thought to be the leading pathogenic factor.
  • [7] Jun 18, 2021 — IgA pemphigus is a vesiculopustular skin disease. In general, lesions form within erythematous plaques but also can form in skin without plaques ...
  • [8] Background IgA pemphigus is a rare neutrophilic acantholytic autoimmune disease that is characterized by IgA deposits on keratinocyte cell surfaces.
  • [9] IgA pemphigus is a rare autoimmune bullous disorder characterized by painful and pruritic pustular or vesiculobullous skin eruptions that result ...

Additional Characteristics

  • IgA pemphigus, also known as intercellular IgA dermatosis, is a rare autoimmune blistering disorder.
  • Intraepidermal Neutrophilic IgA Dermatosis-Type (IEN-Type)
  • Vesiculopustular Skin Disease
  • painful and pruritic pustular or vesiculobullous skin eruptions

Signs and Symptoms

IgA Pemphigus Signs and Symptoms

IgA pemphigus is a rare autoimmune skin condition that causes blisters, sores, or fluid-filled bumps to form on the skin and mucous membranes. The clinical features of IgA pemphigus include:

  • Blisters: Flaccid blisters are often the first sign of IgA pemphigus [1].
  • Pustules: Pustules are a common presenting symptom, with 75% of patients experiencing them [6].
  • Erythema: Redness and inflammation of the skin can occur.
  • Erosions: Open sores may form after the blisters rupture.
  • Vegetating lesions: These are areas of thickened skin that can become inflamed.

In some cases, IgA pemphigus may be mistaken for other conditions such as hives or eczema without blisters [5].

Systemic Symptoms

While systemic symptoms are usually absent in IgA pemphigus, there is a risk of adverse effects including:

  • Infection: Open sores can become infected.
  • Malignancies: There is a small risk of cancer developing.
  • Adrenal insufficiency: This is a rare but serious condition that affects the adrenal glands.
  • Osteoporosis: Weakened bones can occur due to prolonged use of corticosteroids.

It's essential for patients with IgA pemphigus to be aware of these potential complications and seek medical attention if they experience any unusual symptoms [3].

References: [1] - The clinical features of IgA pemphigus include blisters, pustules, erythema, erosions and vegetating lesions. The first signs are flaccid blisters. [2] - Pemphigus causes blisters on your skin and mucous membranes. [3] - Adverse effects may include infection, malignancies, adrenal insufficiency, and osteoporosis. [4] - Pemphigus is a group of autoimmune skin conditions that cause sores, blisters or fluid-filled bumps to form on your skin and mucus membranes. [5] - Sometimes pemphigoid may look like hives or eczema without blisters. [6] - The systematic review by Kridin showed that the most common presenting symptoms are vesicles (80.8%), pustules (75%), circinate plaques (63.6%), etc.

Additional Symptoms

  • Blisters
  • Erythema
  • Erosions
  • Pustules
  • Vegetating lesions

Diagnostic Tests

Diagnostic Tests for IgA Pemphigus

IgA pemphigus is a rare autoimmune disease that affects the skin and mucous membranes. Diagnosing this condition requires a combination of clinical presentation, histopathology, and laboratory tests.

  • Biopsy: A biopsy is a crucial diagnostic tool for IgA pemphigus. It involves removing a sample of tissue from the affected area and examining it under a microscope. The biopsy can help confirm the presence of IgA antibodies in the skin.
    • According to search result [4], a skin biopsy is necessary for diagnosing IgA pemphigus, along with direct immunofluorescent testing.
  • Direct Immunofluorescence (DIF): DIF is a laboratory test that can detect the presence of IgA antibodies in the skin. It involves applying a fluorescent dye to a sample of skin tissue and examining it under a microscope.
    • Search result [3] states that biopsy studies of perilesional skin or mucosa by direct IF are considered a gold standard for diagnosing pemphigus, which includes IgA pemphigus.
  • Serum Tests: Serum tests can also be used to diagnose IgA pemphigus. These tests involve analyzing the patient's blood serum for the presence of IgA antibodies.
    • Search result [2] mentions that IIF (Indirect Immunofluorescence) serum testing and ELISAs are available serum tests for diagnosing pemphigus, which includes IgA pemphigus.

Other Diagnostic Tests

In addition to biopsy and DIF, other diagnostic tests may be used to rule out other conditions or confirm the diagnosis of IgA pemphigus. These include:

  • Blood Tests: Blood tests can help identify any underlying autoimmune disorders that may be contributing to the development of IgA pemphigus.
    • Search result [5] mentions that blood tests, including a biopsy, are used to test for pemphigus.

Conclusion

Diagnosing IgA pemphigus requires a combination of clinical presentation, histopathology, and laboratory tests. A biopsy is a crucial diagnostic tool, and DIF can help confirm the presence of IgA antibodies in the skin. Serum tests may also be used to diagnose IgA pemphigus.

References

[1] Search result 1: Mar 23, 2023 — Available serum tests include IIFs and ELISAs. [2] Search result 2: Use to assess and monitor IgA pemphigus or other nonclassical pemphigus subtypes with both IgA and IgG cell surface antibodies. [3] Search result 3: ​Biopsy studies of perilesional skin or mucosa by direct IF are considered a gold standard for the diagnosis of pemphigus. [4] Search result 4: Nov 15, 2021 — The diagnosis of IgA pemphigus requires a skin biopsy for histology and direct immunofluorescent testing. [5] Search result 5: A biopsy. A biopsy is a procedure to remove a sample of tissue for testing in a lab.

Additional Diagnostic Tests

  • Blood Tests
  • Biopsy
  • Direct Immunofluorescence (DIF)
  • Serum Tests

Treatment

Treatment Options for IgA Pemphigus

IgA pemphigus, a rare autoimmune skin disorder, requires prompt and effective treatment to manage symptoms and prevent complications. Based on the available information, here are some common drug treatments used to manage IgA pemphigus:

  • Corticosteroids: These are often the mainstay of treatment for mild cases of IgA pemphigus. Corticosteroid creams or ointments may be sufficient to control symptoms in people with mild disease [1].
  • Dapsone: This medication is commonly used to treat IgA pemphigus, especially in cases that are resistant to corticosteroids. Dapsone has antineutrophilic effects and can help reduce inflammation [2].
  • Colchicine, Sulfapyridine, or Acitretin: These medications may be used to treat recalcitrant cases of IgA pemphigus that do not respond to corticosteroids or Dapsone [4], [8].

In some cases, combination therapy with multiple medications may be necessary. For example:

  • Adalimumab and Mycophenolate Mofetil: This combination therapy has been reported as an effective treatment for IgA pemphigus in one case study [9].
  • Immunosuppressant drugs: These may be used to reduce inflammation and prevent further skin damage.

It's essential to note that no single treatment option has been found to be universally effective, and the disease is often recalcitrant to oral steroids and immunosuppressants [5].

References:

[1] Jun 18, 2021 - Corticosteroids are the mainstay of treatment for IgA pemphigus. To minimize adverse effects, slow tapering of corticosteroids is recommended.

[2] Jun 18, 2021 - Dapsone is a medication with antineutrophilic effects that can help reduce inflammation in IgA pemphigus.

[4] by S Al‐Zahawi · 2024 - Recalcitrant cases may be treated by Colchicine, Sulfapyridine, or Acitretin.

[5] by F Schauer · 2018 · Cited by 5 - No treatment option has been found to be universally effective. The disease is often recalcitrant to oral steroids and immunosuppressants.

[8] by S Al‐Zahawi · 2024 - IgA pemphigus is usually treated by Dapsone. Recalcitrant cases may be treated by Colchicine, Sulfapyridine, or Acitretin.

[9] by SM Howell · 2005 · Cited by 84 - Adalimumab and mycophenolate mofetil combination therapy was the only effective and safe treatment.

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of IgA Pemphigus

IgA pemphigus is a rare autoimmune skin disorder, and its differential diagnosis involves several conditions that can present with similar clinical and histological features. Here are some of the key differential diagnoses for IgA pemphigus:

  • Bullous Impetigo: This is a bacterial skin infection that can cause blistering of the skin, similar to IgA pemphigus [1]. However, bullous impetigo typically presents with a more rapid onset and a stronger bacterial odor.
  • Pustular Psoriasis: This is a type of psoriasis that can present with pus-filled blisters, which can be mistaken for IgA pemphigus [2]. However, pustular psoriasis typically involves the palms and soles, whereas IgA pemphigus tends to involve other areas of the body.
  • Linear IgA Bullous Dermatosis: This is a rare autoimmune disorder that can cause blistering of the skin, similar to IgA pemphigus [3]. However, linear IgA bullous dermatosis typically presents with a more linear distribution of blisters and a stronger association with other autoimmune disorders.
  • Dermatitis Herpetiformis: This is a type of celiac disease that can cause blistering of the skin, similar to IgA pemphigus [4]. However, dermatitis herpetiformis typically presents with a more widespread distribution of blisters and a stronger association with gastrointestinal symptoms.

Key Features

  • Autoantibodies: The presence of autoantibodies against the monocyte/granulocyte IgA-Fc receptor (CD89) is a hallmark finding in IgA pemphigus [4].
  • Subcorneal Pustular Dermatosis: This is one of the two subtypes of IgA pemphigus, characterized by blistering of the skin at the subcorneal level [5].
  • Intraepidermal Neutrophilic (IEN) Type: This is the other subtype of IgA pemphigus, characterized by blistering of the skin within the epidermis [6].

References

[1] Context 1: Bacterial skin infection [2] Context 2: Classic subcorneal pustular dermatosis [3] Context 4: Autoantibodies binding to sites containing the monocyte/granulocyte IgA-Fc receptor (CD89) [4] Context 6: The hallmark finding in IgA pemphigus is autoantibodies binding to sites containing the monocyte/granulocyte IgA-Fc receptor (CD89), causing ... [5] Context 5: Major differential diagnoses include bullous impetigo, subcorneal pustular dermatosis, pemphigus foliaceus, linear IgA bullous dermatosis, and ... [6] Context 7: Clinically and histologically, IgA pemphigus is divided into 2 major subtypes: subcorneal pustular dermatosis and intraepidermal neutrophilic (IEN) type.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3704
owl#annotatedSource
t357520
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080851
core#notation
DOID:0080851
oboInOwl#hasDbXref
UMLS_CUI:C1274167
IAO_0000115
A pemphigus that is characterized by painful and pruritic vesiculopustular eruptions. These eruptions form as a result of circulating IgA antibodies against keratinocyte cell surface components responsible for cell to cell adherence.
rdf-schema#label
IgA pemphigus
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_9182
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.